- Invited speaker presentation
- Open Access
Discussion session: biomarker trials
- Various speakers
- Published: 16 November 2015
Keywords
- Public Health
- Trial Design
- Discussion Session
- Combine Presentation
Various speakers In a combined presentation and discussion session, representatives from academia and industry discuss the role of Biomarker trial design and implementation, to improve health by improving trials.
Copyright
© Various speakers 2015
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.